Sensus Healthcare Inc (SRTS)

NASD · Healthcare · Medical Devices · USA

Sensus Healthcare Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.

Sensus Healthcare develops medical devices for treating non-melanoma skin cancer and keloid scars using proprietary low-energy X-ray technology. The company offers the SRT-100, SRT-100+, and SRT-100 Vision systems to dermatologists and radiation oncologists, along with service agreements, consumables, and financing options for equipment acquisition.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Sensus Healthcare Inc stock.

Our verdict on SRTS

Slightly undervalued: intrinsic value $2.49 per share, market price $2.26, margin of safety 9.2% (as of 2026-11-17).

Its liquidation floor, current assets minus every liability, values the shares at $2.49; the price of $2.26 is 9% below that value.

ETFs with the most weight in SRTS

7 more funds hold it; the full list is part of the paid plan.

More on SRTS

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than SRTS in Medical Devices

10 more in this industry show a wider margin of safety.

Is SRTS undervalued or overvalued?

SRTS is slightly undervalued (as of the 2026-11-17 close). Its liquidation floor, current assets minus every liability, values the shares at $2.49; the price of $2.26 is 9% below that value.

What is the intrinsic value of SRTS?

$2.49 per share (as of the 2026-11-17 close), against a market price of $2.26. That is a margin of safety of 9.2%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.